Sennato, S.; Paldino, G.; Bombelli, C.; Mezzani, I.; Petrini, S.; Belcastro, E.; Delfino, D.V.; Fiorentino, F.; Marianecci, C.; Ciogli, A.;
et al. Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics 2025, 17, 1601.
https://doi.org/10.3390/pharmaceutics17121601
AMA Style
Sennato S, Paldino G, Bombelli C, Mezzani I, Petrini S, Belcastro E, Delfino DV, Fiorentino F, Marianecci C, Ciogli A,
et al. Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics. 2025; 17(12):1601.
https://doi.org/10.3390/pharmaceutics17121601
Chicago/Turabian Style
Sennato, Simona, Giorgia Paldino, Cecilia Bombelli, Irene Mezzani, Stefania Petrini, Eugenia Belcastro, Domenico Vittorio Delfino, Francesco Fiorentino, Carlotta Marianecci, Alessia Ciogli,
and et al. 2025. "Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710" Pharmaceutics 17, no. 12: 1601.
https://doi.org/10.3390/pharmaceutics17121601
APA Style
Sennato, S., Paldino, G., Bombelli, C., Mezzani, I., Petrini, S., Belcastro, E., Delfino, D. V., Fiorentino, F., Marianecci, C., Ciogli, A., Rotili, D., Ceccacci, F., & Fierabracci, A.
(2025). Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics, 17(12), 1601.
https://doi.org/10.3390/pharmaceutics17121601
